Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

Recently, mesenchymal stem/stromal cells (MSCs) therapy has become an emerging therapeutic modality for the treatment of inflammatory bowel disease (IBD), given their immunoregulatory and pro-survival attributes. MSCs alleviate dysregulated inflammatory responses through the secretion of a myriad of...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadh, Mohamed J., Mikhailova, Maria V., Rasoolzadegan, Soheil, Falaki, Mojgan, Akhavanfar, Roozbeh, Gonzáles, José Luis Arias, Rigi, Amir, Kiasari, Bahman Abedi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881387/
https://www.ncbi.nlm.nih.gov/pubmed/36707899
http://dx.doi.org/10.1186/s40001-023-01008-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881387/
https://www.ncbi.nlm.nih.gov/pubmed/36707899
http://dx.doi.org/10.1186/s40001-023-01008-7

Ejemplares similares